Quick Answer
HAEMONETICS CORP reported Gross Profit of $748.96 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +8.3% in Gross Profit from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $115.44 million | Q2 2014: $106.28 million | Q3 2014: $108.11 million | Q4 2014: $111.66 million | Q1 2015: $108.37 million | Q2 2015: $102.54 million | Q3 2015: $105.30 million | Q4 2015: $108.86 million | Q1 2016: $89.22 million | Q2 2016: $91.06 million | Q3 2016: $104.25 million | Q4 2016: $101.08 million | Q1 2017: $82.11 million | Q2 2017: $91.67 million | Q3 2017: $104.56 million | Q4 2017: $111.30 million | Q1 2018: $104.39 million | Q2 2018: $83.24 million | Q3 2018: $111.91 million | Q4 2018: $111.18 million | Q1 2019: $111.21 million | Q2 2019: $115.91 million | Q3 2019: $127.00 million | Q4 2019: $128.05 million | Q1 2020: $113.56 million | Q2 2020: $90.03 million | Q3 2020: $105.74 million | Q4 2020: $120.26 million | Q1 2021: $81.81 million | Q2 2021: $108.09 million | Q3 2021: $122.54 million | Q4 2021: $138.57 million | Q2 2022: $142.26 million | Q3 2022: $157.88 million | Q4 2022: $158.71 million | Q2 2023: $167.27 million | Q3 2023: $170.51 million | Q4 2023: $177.87 million | Q2 2024: $174.92 million | Q3 2024: $187.44 million | Q4 2024: $193.55 million | Q2 2025: $192.24 million | Q3 2025: $194.74 million | Q4 2025: $202.39 million.
- Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Gross Profit has grown by 143.0%.
- Historical annual values: Fiscal year 2025: $748.96 million | Fiscal year 2024: $691.55 million | Fiscal year 2023: $615.10 million | Fiscal year 2022: $505.50 million | Fiscal year 2021: $397.84 million | Fiscal year 2020: $484.51 million | Fiscal year 2019: $417.54 million | Fiscal year 2018: $411.91 million | Fiscal year 2017: $378.49 million | Fiscal year 2016: $405.91 million | Fiscal year 2015: $434.42 million | Fiscal year 2014: $468.37 million | Fiscal year 2013: $428.13 million | Fiscal year 2012: $369.24 million | Fiscal year 2011: $355.21 million | Fiscal year 2010: $337.48 million | Fiscal year 2009: $308.17 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: